Please login to the form below

Not currently logged in

Havas Health & You appoints Pat Thistlethwaite as chief experience officer

In addition to taking on the new role, Thistlethwaite will continue to serve as managing director

Havas Health & You (HH&Y) has announced the appointment of Pat Thistlethwaite (pictured above) as chief experience officer, as the company seeks to strengthen its capabilities in innovation and customer experience.

In addition to taking on the new role of chief experience officer, Thistlethwaite will also continue in his role as managing director of Havas Health CX.

Prior to joining HH&Y, Thistlethwaite worked as a Design Thinking Advisory Board Member at Rutgers University, and also previously served as managing director of data, analytics and activation at Evoke.

His additional previous positions include managing director, North America at Across Health a well as a number of marketing and commercial roles at Pfizer.

“We are witnessing a revolution in how we treat, cure and care for patients, and in how we communicate about and experience our health overall. Successful health companies will take a complex, data-driven approach that considers the sum of interactions that consumers have with their brands, carefully curating each step and taking a personalised approach to designing their experience,” commented Thistlethwaite.

He added:  “Strategy, content, data, and innovation will work in harmony in a way that dramatically improves how players across the spectrum of health interact, ultimately with the goal of measurably improving the lives and health outcomes of people around the world.”

21st April 2021

From: Marketing



COVID-19 Updates and Daily News

Featured jobs


Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....